Pharmaceutical Product Information
Tecentriq® (atezolizumab)
Roche update on Phase III study of Tecentriq in combination with paclitaxel for people with metastatic triple-negative breast cancer - IMpassion131 results.
Patients
Consumer Medicine Information (CMI)
Healthcare Professionals
Product Information (PI)